IgA Nephropathy Therapeutics Pipeline is Witnessing Significant Growth Due to Unavailability of Specific Treatment: P&S Intelligence
30 oct. 2018 02h35 HE
|
Prescient & Strategic Intelligence
Immunoglobulin A (IgA) Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025 NEW YORK,...